Taken together, our data from both tumor models and in vitro studies show that CXCR2 activation is associated with activation of the MAPK cascade, AKT, and WNT signaling, expression of chemokines that recruit MDSCs and pro-tumor macrophages, and enhanced tumor growth. This evidence concerns the gene AKT1 and neoplasm.